
NEO AUVRA
An advanced VR, AR, XR and biometrics platform enabling precise actionable guidance for optimized brain function and overall health.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 | round | |
N/A | $500k | Seed | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 78 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
NEO AUVRA Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş., operating as NEO AUVRA, was established in Uskudar, Turkey, and officially registered on September 3, 2021. The company was founded by Bekir Tarcan Kiper and Ömer Kerem Özçakıl. Tarcan Kiper, the CEO and co-founder, holds an MSc in Electrical Engineering and Applied Physics and a BSc in Electrical/Electronics Engineering, and has a background as a speaker and author on digital health and virtual reality. Co-founder Kerem Özçakıl brings over 25 years of experience in sales and marketing from various sectors, including telecommunications and cloud technologies. The company secured a significant milestone on January 25, 2022, when Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. invested $1,200,000 for a 9.09% stake.
NEO AUVRA operates in the digital health sector, focusing on holistic well-being by integrating cognitive, emotional, and physical health states. The business model is centered on a "Convergent Model," which brings together a diverse team of neuroscientists, game designers, software developers, and clinical researchers to innovate. The company develops cyber-physical systems and technologies for digital medicine and therapeutics. Its platform offers assessments, reporting, and training exercises designed to improve an individual's overall health. The technology utilizes virtual reality (VR), augmented reality (AR), and extended reality (XR) for interactive scenarios, combined with biometric data collection from sensors and wearables for high-fidelity assessments. This provides quantitative and impartial data on cognitive abilities like memory, attention, and problem-solving. The primary goal is to offer personalized and preventive roadmaps to optimize brain health and overall performance.
The company's services are tailored for four main markets: Neuropsychology/Neurodegenerative Diseases, Human Resources, Fitness and Sports, and general Well-being. Its client base is broad, including athletes, business professionals, and organizations in high-stakes fields like healthcare. For instance, human resources departments can use the platform for talent acquisition and management. The modular architecture of NEO AUVRA's platform allows for the creation of bespoke solutions to meet specific assessment and training needs within these markets. By using VR to simulate realistic environments, the assessments aim for high ecological validity, meaning the results are more reflective of real-life performance compared to traditional methods.
Keywords: digital health, virtual reality assessment, neuropsychological assessment, cognitive training, biometric data, brain health optimization, cyber-physical systems, neurodegenerative diseases, corporate wellness, sports performance, human resources technology, preventive healthcare, VR therapy, AR health, digital therapeutics, cognitive performance, immersive health, psychomotor assessment, salutogenics, clinical research tools